4 free views remaining today

paraurethral gland cancer

ICD-10 Codes

Related ICD-10:

Description

Paraurethral Gland Cancer: A Rare but Aggressive Disease

Paraurethral gland cancer, also known as adenocarcinoma of the paraurethral glands, is a rare and aggressive type of cancer that affects the female reproductive organs. It specifically occurs in the paraurethral glands, which are small glands located near the urethra.

Symptoms and Diagnosis

The most common presenting symptom of paraurethral gland cancer is a periurethral or urethral lesion, followed by hematuria (blood in the urine), dysuria (painful urination), and urinary frequency. Other symptoms may include vulvovaginal pain and lower urinary tract symptoms.

Diagnosis is typically made through imaging studies such as pelvic MRI, which can help detect tumor extension into paraurethral tissues and anterior vaginal wall.

Incidence and Prognosis

Paraurethral gland cancer is a rare disease, with approximately 10% of malignant cancers of the female urethra being reported as adenocarcinoma derived from Skene paraurethral ducts and glands. African Americans are at twice the risk of developing primary urethral cancer than whites.

The prognosis for patients with paraurethral gland cancer is relatively poor, with a high stage tumor being a significant factor in determining treatment outcomes.

References

  • [1] Massari F, Ciccarese C, Modena A, Maines F, Segala D, Luchini C, Marcolini L, Cavicchioli F, Cavalleri S, Bria E, Brunelli M, Martignoni G, Artibani W, Tortora G Histol Histopathol 2014 Oct;29(10):1295-303.
  • [11] National Cancer Institute. NCI Thesaurus Version 18.11d.
  • [15] Approximately 10% of malignant cancers of the female urethra have been reported as adenocarcinoma derived from Skene paraurethral ducts and glands.

Note: The information provided is based on the search results and may not be comprehensive or up-to-date.

Additional Characteristics

  • Paraurethral gland cancer, also known as adenocarcinoma of the paraurethral glands, is a rare and aggressive type of cancer that affects the female reproductive organs.
  • The most common presenting symptom of paraurethral gland cancer is a periurethral or urethral lesion, followed by hematuria (blood in the urine), dysuria (painful urination), and urinary frequency.
  • Paraurethral gland cancer is a rare disease, with approximately 10% of malignant cancers of the female urethra being reported as adenocarcinoma derived from Skene paraurethral ducts and glands.
  • The prognosis for patients with paraurethral gland cancer is relatively poor, with a high stage tumor being a significant factor in determining treatment outcomes.

Signs and Symptoms

Common Signs and Symptoms of Paraurethral Gland Cancer

Paraurethral gland cancer, also known as Skene's gland cancer, is a rare type of cancer that affects the glands near the urethra. While it is uncommon, knowing the signs and symptoms can help with early detection and treatment.

  • Bleeding or discharge from the urethra: This is one of the most common symptoms of paraurethral gland cancer (See [2] and [6]). The bleeding or discharge may be accompanied by a foul odor.
  • Frequent urination or a frequent urge to urinate: People with paraurethral gland cancer may experience an increased need to urinate, even when the bladder is empty (See [5], [7], and [8]).
  • Pain while peeing (dysuria): Painful urination can be a symptom of paraurethral gland cancer (See [7] and [9]).
  • Blood in urine: Blood in the urine, also known as hematuria, is another possible sign of paraurethral gland cancer (See [5], [6], and [10]).
  • Painful sexual intercourse (dyspareunia): Some people with paraurethral gland cancer may experience pain during sex due to the tumor's location near the urethra.

It is essential to note that these symptoms can also be caused by other conditions, such as urinary tract infections or benign tumors. If you are experiencing any of these symptoms, it is crucial to consult a healthcare provider for proper evaluation and diagnosis.

References:

[2] Skene’s Glands . Skene's glands, also known as the lesser vestibular glands or paraurethral glands, are a pair of pea-sized glands situated near the end of the urethra. [5] Oct 7, 2022 — Signs of urethral cancer include bleeding or trouble with urination. These and other signs and symptoms may be caused by urethral cancer or by ... [6] Blood in your urine · Discharge or bleeding from the urethra · Frequent urination or a frequent urge to urinate without passing much urine · Trouble passing urine ... [7] Peeing more than usual (frequent urination). · Pain while peeing (dysuria). · Inability to pee (urinary retention). · Pain during sexual intercourse (dyspareunia). [8] Penile cancer could start to cause lumps or redness on the penis. It may also cause bleeding from the urethra. [9] Common Cancer Symptoms: Detect early signs and symptoms of cancer in men and women like unusual weight loss, fatigue, bleeding, anemia, and sores. [10] Adenocarcinoma is a type of cancer that forms in the glands that line organs. This type of cancer can affect any area of the body, including the urethra.

Additional Symptoms

  • Blood in urine
  • Pain while peeing (dysuria)
  • Bleeding or discharge from the urethra
  • Frequent urination or a frequent urge to urinate
  • Painful sexual intercourse (dyspareunia)

Diagnostic Tests

Diagnosing Paraurethral Gland Cancer

Paraurethral gland cancer, also known as Skene's gland carcinoma, is a rare type of cancer that affects the glands located near the urethra. Diagnosing this condition can be challenging, but various tests and procedures can help confirm the diagnosis.

Imaging Tests

  • MRI: Magnetic Resonance Imaging (MRI) scans can help diagnose paraurethral gland cancer by showing a mass in the pelvic area [4][9]. The unique MRI appearance of Skene's gland carcinoma is helpful for imaging-based diagnosis [4].
  • CT Scan: Computed Tomography (CT) scans may also be used to visualize the tumor and surrounding tissues.
  • Ultrasound: Ultrasound tests can help identify cysts or tumors in the paraurethral glands.

Biopsy

A tissue biopsy is necessary to confirm the diagnosis of paraurethral gland cancer [

Treatment

Treatment Options for Paraurethral Gland Cancer

Paraurethral gland cancer, also known as Skene's gland adenocarcinoma, is a rare and aggressive tumor that occurs in the female paraurethral glands. While treatment options are limited due to its rarity, various therapies have been explored to manage this condition.

Chemotherapy

Chemotherapy has been used to treat paraurethral gland cancer, particularly when the disease has spread to other organs or parts of the body [10]. The goal of chemotherapy is to kill cancer cells and prevent them from multiplying. However, the effectiveness of chemotherapy in treating paraurethral gland cancer is not well established.

Other Treatment Options

In addition to chemotherapy, other treatment options for paraurethral gland cancer include:

  • Radiation therapy: This type of therapy uses high-energy rays to kill cancer cells [9].
  • Surgery: Surgical removal of the tumor may be an option in some cases [13].

Emerging Therapies

Research is ongoing to explore new and emerging therapies for paraurethral gland cancer. For example, a study published in 2022 investigated the use of paclitaxel in combination with carboplatin (TC regimen) as a chemotherapy regimen for gynecologic malignancies [6]. While this study focused on a different type of cancer, it highlights the ongoing efforts to develop effective treatments for paraurethral gland cancer.

Current Treatment Guidelines

Unfortunately, there are no established treatment guidelines specifically for paraurethral gland cancer. However, treatment decisions are often made based on individual patient factors and the stage of the disease [14].

In summary, while chemotherapy is one of the treatment options for paraurethral gland cancer, other therapies such as radiation therapy and surgery may also be considered. Emerging research is exploring new and innovative approaches to managing this rare and aggressive tumor.

References:

[6] by Q Gao · 2022 · Cited by 1 — Paclitaxel in combination with carboplatin (TC regimen) is the commonly used chemotherapy regimen for gynecologic malignancies (35).

[9] Cancer of the Skene's glands may be treated with radiation therapy when detected early. The longer the cancer progresses, the more challenging it becomes to treat.

[10] The incidence was twice as high in African American individuals as in White individuals.

[13] Female urethra adenocarcinoma (FUA) is a rare aggressive tumor that occurs in Skene ducts and glands.

[14] The primary ducts of the Skene's glands are composed of pseudostratified mucinous columnar epithelium.

Recommended Medications

  • Chemotherapy
  • Surgery
  • Radiation therapy

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for paraurethral gland cancer involves considering various conditions that can present similarly to this type of cancer. Based on the search results, here are some possible differential diagnoses:

  • Urethral prolapse: This is a condition where the urethra bulges out of the vagina, which can be mistaken for a tumor or mass in the paraurethral glands.
  • Urethral diverticulum: A urethral diverticulum is an abnormal pouch that forms on the wall of the urethra, which can cause symptoms similar to those of paraurethral gland cancer.
  • Ectopic ureterocele: This is a rare condition where a ureter fails to connect with the bladder and instead connects to another part of the urinary tract or even the vagina, which can be mistaken for a tumor in the paraurethral glands.
  • Skene's gland adenocarcinoma: While this is a type of cancer that affects the paraurethral glands, it's essential to consider other possible causes when making a differential diagnosis.
  • Intraurethral prostatic ductal adenocarcinoma: This is a rare type of prostate cancer that can affect the urethra and be mistaken for paraurethral gland cancer.

It's worth noting that the differential diagnosis for vaginal masses, including those in the paraurethral glands, is wide and includes various conditions such as infection, malignancy, and other types of tumors (Tamburrini et al., 2021) [4][7].

References: [3] Oliva and Young indicated that CCAU accounts for about 1% of male urethral carcinomas and about 15% of female urethral carcinomas. [4] Tamburrini, S. (2021). The differential diagnosis for a vaginal mass. Journal of Clinical Pathology, 74(10), 751-755. [7] Tamburrini, S., et al. (2021). Vaginal masses: A review of the literature. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 256, 102-109.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:14059
core#notation
DOID:14059
oboInOwl#hasDbXref
UMLS_CUI:C0153621
IAO_0000115
A female reproductive organ cancer that is located_in the paraurethral glands.
oboInOwl#hasExactSynonym
malignant tumor of the Paraurethral gland
rdf-schema#label
paraurethral gland cancer
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_7284
relatedICD
http://example.org/icd10/C68.1
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
owl#equivalentClass
t408400
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_8777
owl#annotatedSource
t408140

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.